Following an extensive 2-year infrastructure project developing, validating, and refining our data management structure through a comprehensive Electronic Lab Notebook implementation, BioIVT has developed new, tiered in vitro ADME study options to match quality, timeline, and cost needs with individual client programs. Three standardized tiers, targeted to study purpose and compound development stage, were developed based on alignment of our scientific and regulatory submission expertise with client requests and feedback. We also expanded our internal support for custom-tailored studies.

Applicable study types include enzyme inhibition and induction, reaction phenotyping, metabolic stability, metabolite ID, and transporter substrate and inhibition evaluations. Our BioIVT.com service pages outline these new tiers, allowing you to quickly and easily view recommended study designs and customize quotes based on your specific needs and end goals. However, this webinar will provide insight into the industry trends and compound progression strategies behind the tiered design, as well as touch on the process streamlining and lab digitization approaches carefully applied to make this possible.

Primary Takeaways/What You’ll Learn:

• What are the new tiers and why were they developed?
• Which tier is right for me and my program?
• What benefits do the new tiers provide?